Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.145 AUD
Market Cap: AU$42.4m

Relative Value

The Relative Value of one NXS stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.145 AUD, Next Science Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NXS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

NXS Competitors Multiples
Next Science Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Next Science Ltd
ASX:NXS
42.4m AUD 1.4 -3.2 -3.9 -3.9
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 38.1 27.6 33.1
US
Medline Inc
NASDAQ:MDLN
55.2B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
28.4B CHF 3.5 37.3 14.4 27.9
DK
Coloplast A/S
CSE:COLO B
94.8B DKK 3.5 24.6 13 15.5
US
Align Technology Inc
NASDAQ:ALGN
12.8B USD 3.2 31.2 13.4 18.5
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 2.4 33.1 11.6 18.1
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 1.1 -15.4 16.8 54.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
39.3B CNY 8.6 23.8 21.4 21.4
JP
Asahi Intecc Co Ltd
TSE:7747
870.8B JPY 6.7 49.2 23.3 31.6
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.3B CNY 3.8 21.9 32.5 32.5
P/E Multiple
Earnings Growth PEG
AU
Next Science Ltd
ASX:NXS
Average P/E: 32.4
Negative Multiple: -3.2
N/A N/A
JP
Hoya Corp
TSE:7741
38.1
14%
2.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available
29%
N/A
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.6
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
31.2
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
33.1
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.4 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.8
9%
2.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
49.2
38%
1.3
CN
Intco Medical Technology Co Ltd
SZSE:300677
21.9
12%
1.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Next Science Ltd
ASX:NXS
Average EV/EBITDA: 19.3
Negative Multiple: -3.9
N/A N/A
JP
Hoya Corp
TSE:7741
27.6
12%
2.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
CH
Alcon AG
SIX:ALC
14.4
9%
1.6
DK
Coloplast A/S
CSE:COLO B
13
6%
2.2
US
Align Technology Inc
NASDAQ:ALGN
13.4
14%
1
UK
ConvaTec Group PLC
LSE:CTEC
11.6
11%
1.1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.8
29%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
13%
1.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
23.3
12%
1.9
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.5
51%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Next Science Ltd
ASX:NXS
Average EV/EBIT: 28.1
Negative Multiple: -3.9
N/A N/A
JP
Hoya Corp
TSE:7741
33.1
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
18%
N/A
CH
Alcon AG
SIX:ALC
27.9
26%
1.1
DK
Coloplast A/S
CSE:COLO B
15.5
7%
2.2
US
Align Technology Inc
NASDAQ:ALGN
18.5
21%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
18.1
21%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
54.3
72%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
10%
2.1
JP
A
Asahi Intecc Co Ltd
TSE:7747
31.6
N/A N/A
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.5
24%
1.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett